Literature DB >> 17848844

Atypical thymic carcinoid in multiple endocrine neoplasia type 1 syndrome.

A Vidal1, M J Lorenzo, M L Isidro, F Cordido.   

Abstract

An asymptomatic, non-smoker patient carrier of a multiple endocrine neoplasia syndrome type 1 (MEN1) mutation was diagnosed with invasive atypical thymic carcinoid tumor. After surgical treatment the tumor reappeared albeit without metastasis. Thymic carcinoid is a well-known cause of mortality in MEN1, and usually metastatic disease is present at diagnosis. Male sex, smoking, and previous hyperparathyroidism probably play a role in the pathogenesis of this neoplasia.

Entities:  

Mesh:

Year:  2007        PMID: 17848844     DOI: 10.1007/BF03346355

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  6 in total

1.  Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.

Authors:  P Ferolla; A Falchetti; P Filosso; P Tomassetti; G Tamburrano; N Avenia; G Daddi; F Puma; R Ribacchi; F Santeusanio; G Angeletti; M L Brandi
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

2.  Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.

Authors:  Fathia Gibril; Yuan-Jia Chen; David S Schrump; Alexander Vortmeyer; Zhengping Zhuang; Irina A Lubensky; James C Reynolds; Adeline Louie; Laurence K Entsuah; Kane Huang; Behnam Asgharian; Robert T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

Review 3.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

4.  Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1.

Authors:  J R Burgess; N Giles; J J Shepherd
Journal:  Clin Endocrinol (Oxf)       Date:  2001-11       Impact factor: 3.478

5.  Thymic carcinoids in multiple endocrine neoplasia type 1.

Authors:  B T Teh; J Zedenius; S Kytölä; B Skogseid; J Trotter; H Choplin; S Twigg; F Farnebo; S Giraud; D Cameron; B Robinson; A Calender; C Larsson; P Salmela
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

6.  Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types.

Authors:  Kjell Oberg; Lone Astrup; Barbro Eriksson; Sture E Falkmer; Ursula G Falkmer; Jens Gustafsen; Caj Haglund; Ulrich Knigge; Morten H Vatn; Matti Välimäki
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

  6 in total
  2 in total

Review 1.  Carcinoid tumors.

Authors:  Scott N Pinchot; Kyle Holen; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2008-12-17

2.  Small Bowel Carcinoids: A Single Surgeon's Experience in Southern India.

Authors:  Sreevathsa Maddibande Ramachar; Nishchit Hegde
Journal:  J Clin Diagn Res       Date:  2015-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.